Atypical presentations and complications of GERD

American Journal of Managed Care

Volumn 3, Issue 6 SUPPL. 1, 1997, Pages

  Bortz, David L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008946832     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Deschner WK, Benjamin SB. Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 1989; 84:1-5.
2. Sontag S, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99:613-620.
3. Simpson WG. Gastroesophageal reflux disease and asthma. Diagnosis and Management. Arch Intern Med 1995;155:798-803.
4. Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: A possible reflex mechanism. Ann Allergy 1978;41: 224-226.
5. Donnelly RJ, Berrisford RG, Jack CIA, et al. Simultaneous tracheal and esophageal pH monitoring: Investigating reflux-associated asthma. Ann Thorac Surg 1993;56: 1029-1034.
6. Gastal OL, Castell JA, Castell DO. Frequency and site of gastroesophageal reflux in patients with chest symptoms: Studies using proximal and distal pH monitoring. Chest 1994;106:1793-1796.
7. Boyle JT, Tuchman DN, Altschuler SM, et al. Mechanisms for the association of gastroesophageal reflux and bronchospasm. Am Rev Respir Dis 1985;131:(suppl):S16-S20.
8. Ekström T, Tibbling L. Influence of theophylline on gastro-oesophageal reflux and asthma. Eur J Clin Pharmacol 1988;35:353-356.
9. Castell DO, Donner MW. Evaluation of dysphagia: The careful history is crucial. Dysphagia 1987;2:65-71.
10. Proudfit WL, Shirey EK. Selective cine coronary arteriography: Correlation with clinical findings in 1,000 patients. Circulation 1966;33:901-910.
11. Richter JE. Gastroesophageal reflux disease as a cause of chest pain. In: Richter JE, Beitman BD, Cannon RO III, eds. Unexplained Chest Pain. Philadelphia: W.B.Saunders, 1991.
12. Hewson EG, Sinclair JW, Dalton CB. Twenty-four-hour esophageal pH monitoring: The most useful test for evaluating noncardiac chest pain. Am J Med 1991;90: 576-583.
13. Mellow MH, Simpson AG, Watt L, et al. Esophageal acid perfusion in coronary artery disease. Induction of myocardial ischemia. Gastroenterology 1983;85: 306-312.
14. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51(suppl 1):24-29.
15. Swarbrick ET, Gough AL, Christian J, et al. Prevention of recurrence of oesophageal stricture: A comparative study of lansoprazole and high dose ranitidine. Gastroenterology 1994;106:A189. Abstract.
16. Katz PO, Castell DO. Barren's esophagus: Today's dilemma. Esophagus 1990;3: 55-60.
17. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92: 118-124.
18. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994;89:1844-1848.
19. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastrointestinal Endosc 1992;38:619-622.
20. Berenson MM, Johnson TD, Markowitz NR, et al. Restoration of squamous mucosa after ablation of Barren's esophageal epithelium. Gastroenterology 1993;104:1686-1691.